Day One Biopharmaceuticals Inc (DAWN)
16.18
+0.14
(+0.90%)
USD |
NASDAQ |
May 17, 16:00
16.18
0.00 (0.00%)
After-Hours: 20:00
Day One Biopharmaceuticals Cash from Investing (Quarterly): 89.29M for March 31, 2024
Cash from Investing (Quarterly) Chart
Historical Cash from Investing (Quarterly) Data
| Date | Value |
|---|---|
| March 31, 2024 | 89.29M |
| December 31, 2023 | 30.38M |
| September 30, 2023 | 88.92M |
| June 30, 2023 | 20.27M |
| March 31, 2023 | -11.19M |
| December 31, 2022 | -2.21M |
| September 30, 2022 | -246.85M |
| June 30, 2022 | -5.997M |
| March 31, 2022 | -0.015M |
| Date | Value |
|---|---|
| December 31, 2021 | 0.00 |
| September 30, 2021 | 0.00 |
| June 30, 2021 | 0.00 |
| March 31, 2021 | -8.00M |
| December 31, 2020 | 0.001M |
| September 30, 2020 | 0.00 |
| June 30, 2020 | -0.005M |
| March 31, 2020 | -0.088M |
Cash From Investing Definition
Cash from Investing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall investing activities of the company. A few examples of investing activities include net change in PP&E, and net divestitures.
Cash from Investing (Quarterly) Range, Past 5 Years
-246.85M
Minimum
Sep 2022
89.29M
Maximum
Mar 2024
-2.676M
Average
--
Median
Sep 2020
Cash from Investing (Quarterly) Benchmarks
| Revolution Medicines Inc | -247.97M |
| Zentalis Pharmaceuticals Inc | 61.54M |
| Perspective Therapeutics Inc | -47.30M |
| Electromed Inc | -0.129M |
| Xtant Medical Holdings Inc | -0.674M |
Cash from Investing (Quarterly) Related Metrics
| Cash from Operations (Quarterly) | -49.73M |
| Cash from Financing (Quarterly) | 0.048M |
| Free Cash Flow | -170.60M |
| Free Cash Flow Per Share (Quarterly) | -0.5737 |
| Free Cash Flow Yield | -12.65% |